Award

R01 DK132891

Funder: National Institute of Diabetes and Digestive and Kidney Diseases

Funded outputs count: 6

Funder award ID: R01 DK132891

OpenAlex ID: G7109380669

p16 INK4A drives nonalcoholic fatty liver disease phenotypes in high fat diet fed mice through biliary E2F1/FOXO1/IGF-1 signaling

2023 · Debjyoti Kundu, Lindsey Kennedy, et al. · Hepatology · 23

Preparation and Characterization of IL-22 mRNA-Loaded Lipid Nanoparticles

2023 · Zahra Alghoul, Junsik Sung, et al. · BIO-PROTOCOL · 2

Loss of apical sodium bile acid transporter alters bile acid circulation and reduces biliary damage in cholangitis

2022 · Vik Meadows, Corinn Marakovits, et al. · American Journal of Physiology-Gastrointestinal and Liver Physiology · 14

Lipid Nanoparticles for Oral Delivery of Nucleic Acids for Treating Inflammatory Bowel Disease

2022 · Chunhua Yang, Gianfranco Alpini, et al. · Nanomedicine · 6

Mast cells in liver disease progression: An update on current studies and implications

2021 · Linh Pham, Lindsey Kennedy, et al. · Hepatology · 24

Mast Cells Regulate Ductular Reaction and Intestinal Inflammation in Cholestasis Through Farnesoid X Receptor Signaling

2021 · Vik Meadows, Lindsey Kennedy, et al. · Hepatology · 70